Mount Sinai Beth Israel Hospital — New York, New York

Mount Sinai Beth Israel Hospital is a clinical research site located in New York, New York, United States 10003.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Mount Sinai Beth Israel Hospital has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: Primary Tumor, Renal Cell Carcinoma, COVID.

Sponsors: Beth Israel Medical Center, University of Minnesota, Icahn School of Medicine at Mount Sinai.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai Beth Israel Hospital?

Mount Sinai Beth Israel Hospital has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai Beth Israel Hospital conducted?

Mount Sinai Beth Israel Hospital has 4 clinical trials on record, with 2 currently active. Their work covers Primary Tumor, Renal Cell Carcinoma, COVID.

Is Mount Sinai Beth Israel Hospital accredited by Crixeo Health?

Mount Sinai Beth Israel Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai Beth Israel Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.